LEDBURY HEALTH PARTNERSHIP
LEDBURY MARKET P/SHIP, MARKET STREET, LEDBURY
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 86 | 96 | 89.6% | |
| STROKE 9 | 2006 | 111 | 119 | 93.3% | |
| Stroke 12 | 2007 | 112 | 125 | 89.6% | |
| Stroke 12 | 2008 | 117 | 124 | 94.4% | |
| Stroke 12 | 2009 | 115 | 119 | 96.6% | |
| Stroke 12 | 2010 | 115 | 126 | 91.3% | |
| STROKE 12 | 2011 | 110 | 118 | 93.2% | |
| STROKE 12 | 2012 | 107 | 119 | 89.9% | |
| STROKE 12 | 2013 | 93 | 102 | 91.2% | |
| STIA007 | 2014 | 94 | 101 | 93.1% | |
| STIA007 | 2015 | 98 | 99 | 99.0% | |
| STIA007 | 2016 | 107 | 109 | 98.2% | |
| STIA007 | 2017 | 115 | 117 | 98.3% | |
| STIA007 | 2018 | 117 | 118 | 99.2% | |
| STIA007 | 2019 | 130 | 133 | 97.7% | |
| STIA007 | 2020 | 130 | 133 | 97.7% | |
| STIA007 | 2021 | 206 | 229 | 90.0% | |
| STIA007 | 2022 | 230 | 232 | 99.1% | |
| STIA007 | 2023 | 246 | 249 | 98.8% |
